The effect of intra - articular sustained release delivery systems of glucocorticoid on the outcome of temporomandibular joint arthrocentesis / Tarik Alkhader Mohammed Alazzani ; Supervised Hamida Refai Hassanien , Nadia Galal
Material type: TextLanguage: English Publication details: Cairo : Tarik Alkhader Mohammed Alazzani , 2013Description: 83 Leaves : facsimiles ; 30cmOther title:- {uFE97}{uFE84}{uFE9B}{uFBFF}{uFEAE} {uFEE7}{uFEC8}{uFE8E}م و{uئإؤ٧}{uئإؤ٢} {uئإ٩٧}{uئإء٤}{uئإءإ}{uئآئإ}{uئإءإ} {uئإإ٣}{uئإ٨إ}دة ا{uئإؤئ}{uئإء٠}{uئإإ٠}{uئآئئ}{uئإؤأ}{uئإإإ}{uئإؤآ}{uئإإإ}ر{uئإ٩٧}{uئآئئ}{uئإؤأ}{uئإإإ}{uئآئإ}{uئإءإ} دا{uئإء٧}{uئإؤإ} ا{uئإؤئ}{uئإإ٤}{uئإؤ٤}{uئإآأ}{uئإإ٠}{uئآئئ}{uئإ٩٤} {uئإأآ}{uئإإ٠}{uئإئ٠} {uئإإ٧}{uئإ٩٨}{uئإ٨إ}{uئإ٨آ}{uئإ٩إ} {uئإأئ}{uئإآ٤}{uئآئئ}{uئإؤإ} ا{uئإؤئ}{uئإإ٤}{uئإؤ٤}{uئإآأ}{uئإؤإ} ا{uئإؤئ}{uئإآ٤}{uئإؤ٤}لى ا{uئإؤئ}{uئإآأ}{uئإءء}غى [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.09.13.M.Sc.2013.Ta.E (Browse shelf(Opens below)) | Not for loan | 01010110065529000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.09.13.M.Sc.2013.Ta.E (Browse shelf(Opens below)) | 65529.CD | Not for loan | 01020110065529000 |
Thesis (M.Sc.) - Cairo University - Faculty of Oral and Dental Medicine - Department of Oral and Maxillofacial Surgery
The aim of this study was to assess the clinical effect of a single intra-articular injection of dexamethasone 21 - palmitate (lipotalon®) versus methylprednisolone acetate (depomedrole) on the outcome of temporomandibular joint arthrocentesis. Eighteen females out of 38 patients (47.4%) did not respond to the used conservative therapy. Their ages ranged from 17 - 34 years, with an average of 24.2 years. The patients were randomly assigned in into 1 of 2 equal groups. This group assignment was kept blinded to the patients and research candidate. Group A: Arthrocentesis with intra articular injection of {u00BD} ml of lipotalon (4mg/ml) at the end of the procedure was performed.Group B: Arthrocentesis with intra articular injection of {u00BD}ml of depomedrole (40mg / 2ml) at the end of the procedure was performed. The clinical outcome measure parameters were assessed at baseline, i.e. before arthrocentesis, and then again at 1, 3 and 7 weeks and 5 months postoperatively. The evaluated parameters include assessment of articular pain (0 - 10 NRS), MMO and mandibular dysfunction as expressed by Helkimo index scores. Both groups showed significant decrease in mean NRS, significant increase in the mean MMO and significant decrease in helkimo index scores through all the study periods
Issued also as CD
There are no comments on this title.